Cooper Alex D, Josephs Keith A
Department of Neurology, Mayo Clinic, 200 1st Street SW, Rochester, MN 55905, USA.
Parkinsonism Relat Disord. 2009 Jan;15(1):59-61. doi: 10.1016/j.parkreldis.2008.01.011. Epub 2008 Mar 6.
Progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) have overlapping clinical features that can make clinical distinction between these two entities difficult. The present study compared the frequency of photophobia, visual hallucinations, and REM sleep behavior disorder (RBD) in patients clinically diagnosed with PSP to those clinically suspected to have CBD. Photophobia occurred in all 10 (100%) PSP patients vs 2 (18%) patients with clinically suspected CBD (p=0.0002). Visual hallucinations and RBD occurred in patients with PSP and CBD but were rare occurrences (5% for each symptom). The presence of photophobia is significantly more frequent in clinically diagnosed PSP than CBD and can be used as a feature in differentiating between the two diseases in clinical practice. Visual hallucinations and RBD occur infrequently in PSP and CBD and are not useful symptoms in clinical differentiation.
进行性核上性麻痹(PSP)和皮质基底节变性(CBD)具有重叠的临床特征,这使得临床上区分这两种疾病很困难。本研究比较了临床诊断为PSP的患者与临床怀疑患有CBD的患者中畏光、视幻觉和快速眼动睡眠行为障碍(RBD)的发生频率。10例(100%)PSP患者均出现畏光,而临床怀疑患有CBD的患者中有2例(18%)出现畏光(p = 0.0002)。视幻觉和RBD在PSP和CBD患者中均有发生,但发生率较低(每种症状均为5%)。临床诊断的PSP中畏光的出现频率明显高于CBD,在临床实践中可作为区分这两种疾病的一个特征。视幻觉和RBD在PSP和CBD中很少发生,在临床鉴别中不是有用的症状。